• Steffen Massberg, Lenka Grahl, Marie-Luise von Bruehl, Davit Manukyan, Susanne Pfeiler, Christian Goosmann, Volker Brinkmann, Michael Lorenz, Kiril Bidzhekov, Avinash B Khandagale, Ildiko Konrad, Elisabeth Kennerknecht, Katja Reges, Stefan Holdenrieder, Siegmund Braun, Christoph Reinhardt, Michael Spannagl, Klaus T Preissner, and Bernd Engelmann.
• Deutsches Herzzentrum, Technische Universität, Munich, Germany.
• Nat. Med. 2010 Aug 1;16(8):887-96.

AbstractBlood neutrophils provide the first line of defense against pathogens but have also been implicated in thrombotic processes. This dual function of neutrophils could reflect an evolutionarily conserved association between blood coagulation and antimicrobial defense, although the molecular determinants and in vivo significance of this association remain unclear. Here we show that major microbicidal effectors of neutrophils, the serine proteases neutrophil elastase and cathepsin G, together with externalized nucleosomes, promote coagulation and intravascular thrombus growth in vivo. The serine proteases and extracellular nucleosomes enhance tissue factor- and factor XII-dependent coagulation in a process involving local proteolysis of the coagulation suppressor tissue factor pathway inhibitor. During systemic infection, activation of coagulation fosters compartmentalization of bacteria in liver microvessels and reduces bacterial invasion into tissue. In the absence of a pathogen challenge, neutrophil-derived serine proteases and nucleosomes can contribute to large-vessel thrombosis, the main trigger of myocardial infarction and stroke. The ability of coagulation to suppress pathogen dissemination indicates that microvessel thrombosis represents a physiological tool of host defense.

47 keywords...

hide…